Our purpose
Improve people's lives
![Therapeutic areas](https://www.esteve.com/rc/img/area/areas-terapeuticas.jpg)
Therapeutic areas
Find out more![Contract Manufacturing](https://www.esteve.com/rc/img/area/cmo2.png)
Contract Manufacturing
Find out more![R&D](https://www.esteve.com/rc/img/area/i+d.jpg)
R&D
Find out more![Patients](https://www.esteve.com/rc/img/area/pacientes.jpg)
Patients
Find out moreAbout us
Learn how we've been delivering on our mission for patients for 90 years.
Media
![](https://www.esteve.com/GetFichero.do?con=3669&zon=3&fichero=Ar_3_3_3669_IL_1.jpg)
ESTEVE WILL INVEST 100 MILLION EUROS IN THE CONSTRUCTION OF A NEW PLANT AT ITS INDUSTRIAL CENTRE IN CELRÀ (GIRONA)
The company expects the new facilities to be operational in the last quarter of 2026.
This unit will allow the company's production capacity to increase globally ...
28/06/2024
Read more![](https://www.esteve.com/GetFichero.do?con=3668&zon=3&fichero=Ar_3_3_3668_IL_1.jpg)
ESTEVE CONSOLIDATES ITS DOUBLE-DIGIT GROWTH AND REACHES €710 MILLION IN NET INCOME
The company advances in its vision to be a leading international specialty pharmaceutical company, growing in Europe and expanding the portfolio
ESTEVE's medicine...
16/05/2024
Read more![](https://www.esteve.com/GetFichero.do?con=3667&zon=3&fichero=Ar_3_3_3667_IL_1.jpg)
ESTEVE SIGNS A BINDING OFFER TO ACQUIRE HRA PHARMA RARE DISEASES, A PERRIGO COMPANY AFFILIATE
ESTEVE will increase its rare and severe diseases portfolio with three medicines addressing Cushing's syndrome and Adrenocortical Carcinoma.
This is a step forwar...
25/04/2024
Read more![Our global presence](https://www.esteve.com/rc/img/area/presencia-mundo.png)
Our global presence
Get our latest news and media resources
Go![Enter the ESTEVE Media](https://www.esteve.com/rc/img/claim/media/corporate-resources/discover.jpg)